Cash flow MatsukiyoCocokara & Co.

Stocks

3088

JP3869010003

Drug Retailers

Market Closed - Japan Exchange Other stock markets 12:00:00 11/06/2026 pm IST			5-day change	1st Jan Change
2,358.00 ^JPY	-1.26%		+4.89%	-13.05%

14/05	MatsukiyoCocokara & Co.'s Equity Buyback announced on May 13, 2026, has closed with 4,617,700 shares, representing 1.16% for ¥10,745.39 million.	CI
14/05	Tranche Update on MatsukiyoCocokara & Co.'s Equity Buyback Plan announced on May 13, 2026.	CI

0bae8885c4144450.D8Mf3E__yvbItTNax9ee8tMnaIuvUkODb4vGBQ_fB_w.X6dwlBmui5_x5HhsrILwxLxFH8X-azDqGvGof1ulVbJYjU6sCJeavP3ACw

Published financial data: MATSUKIYOCOCOKARA & CO.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	56TCr	73TCr	95TCr	1,02300Cr	1,06200Cr
Total Revenues	56TCr	73TCr	95TCr	1,02300Cr	1,06200Cr
Cost of Goods Sold, Total	37TCr	49TCr	62TCr	67TCr	69TCr
Gross Profit	18TCr	24TCr	33TCr	35TCr	37TCr
Selling General & Admin Expenses, Total	14TCr	18TCr	25TCr	26TCr	27TCr
Provision for Bad Debts	1.2Cr	-	-	5.4Cr	-
Depreciation & Amortization - (IS)	773.8Cr	1.11TCr	1.42TCr	1.57TCr	1.61TCr
Amortization of Goodwill and Intangible Assets - (IS)	84Cr	380.9Cr	657.5Cr	658.4Cr	647.8Cr
Other Operating Expenses	1.1Cr	1.1Cr	-1.3Cr	80L	16Cr
Other Operating Expenses, Total	15TCr	20TCr	27TCr	28TCr	29TCr
Operating Income	3.15TCr	4.14TCr	6.23TCr	7.57TCr	8.21TCr
Interest Expense, Total	-4.4Cr	-6Cr	-5.3Cr	-5.7Cr	-6.4Cr
Interest And Investment Income	50Cr	52Cr	57Cr	62Cr	62Cr
Net Interest Expenses	45Cr	46Cr	52Cr	56Cr	55Cr
Income (Loss) On Equity Invest.	-	-30Cr	-	-	-
Currency Exchange Gains (Loss)	-	-	-	-	-
Other Non Operating Income (Expenses)	211.6Cr	331.7Cr	392.7Cr	428.3Cr	363.4Cr
EBT, Excl. Unusual Items	3.41TCr	4.49TCr	6.67TCr	8.05TCr	8.63TCr
Gain (Loss) On Sale Of Investments	35Cr	1.05TCr	-6.9Cr	274.1Cr	80L
Gain (Loss) On Sale Of Assets	2Cr	-3.6Cr	65Cr	-4.1Cr	53Cr
Asset Writedown	-60Cr	-488.3Cr	-189.8Cr	-237.6Cr	-271.7Cr
Other Unusual Items	-124.6Cr	-82Cr	-49Cr	42Cr	-20Cr
EBT, Incl. Unusual Items	3.26TCr	4.96TCr	6.49TCr	8.12TCr	8.39TCr
Income Tax Expense	1.1TCr	1.5TCr	2.41TCr	2.86TCr	2.89TCr
Earnings From Continuing Operations	2.16TCr	3.46TCr	4.08TCr	5.26TCr	5.5TCr
Net Income to Company	2.16TCr	3.46TCr	4.08TCr	5.26TCr	5.5TCr
Minority Interest	-	-2.4Cr	-22Cr	-27Cr	-33Cr
Net Income - (IS)	2.16TCr	3.46TCr	4.05TCr	5.23TCr	5.47TCr
Net Income to Common Incl Extra Items	2.16TCr	3.46TCr	4.05TCr	5.23TCr	5.47TCr
Net Income to Common Excl. Extra Items	2.16TCr	3.46TCr	4.05TCr	5.23TCr	5.47TCr
Per Share Items
Net EPS - Basic	70.04	94.38	96.02	125.31	133.85
Basic EPS - Continuing Operations	70.04	94.38	96.02	125.31	133.85
Basic Weighted Average Shares Outstanding	31Cr	37Cr	42Cr	42Cr	41Cr
Net EPS - Diluted	70.01	94.35	95.99	125.28	133.81
Diluted EPS - Continuing Operations	70.01	94.35	95.99	125.28	133.81
Diluted Weighted Average Shares Outstanding	31Cr	37Cr	42Cr	42Cr	41Cr
Normalized Basic EPS	69.19	76.48	98.23	119.79	131.18
Normalized Diluted EPS	69.16	76.45	98.2	119.76	131.14
Dividend Per Share	23.33	23.33	23.33	37	44
Payout Ratio	33.35	23.92	26.09	25.32	30.78
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	4.01TCr	5.63TCr	8.31TCr	9.8TCr	10TCr
EBITA	3.24TCr	4.52TCr	6.89TCr	8.22TCr	8.86TCr
EBIT	3.15TCr	4.14TCr	6.23TCr	7.57TCr	8.21TCr
EBITDAR	7.63TCr	11TCr	15TCr	17TCr	18TCr
Effective Tax Rate - (Ratio)	33.87	30.26	37.19	35.24	34.43
Normalized Net Income	2.13TCr	2.8TCr	4.15TCr	5TCr	5.36TCr
Non-Cash Pension Expense	3.6Cr	12Cr	13Cr	6.6Cr	3.7Cr
Supplemental Operating Expense Items
Advertising Expense	139.7Cr	168.6Cr	213.1Cr	225Cr	218Cr
Selling and Marketing Expenses	139.7Cr	168.6Cr	213.1Cr	225Cr	218Cr
Net Rental Expense, Total	3.62TCr	5.14TCr	6.73TCr	7.12TCr	7.43TCr
Imputed Operating Lease Interest Expense	53Cr	105.82Cr	128.66Cr	154.21Cr	332.88Cr
Imputed Operating Lease Depreciation	3.57TCr	5.03TCr	6.6TCr	6.96TCr	7.1TCr

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	3.85TCr	7.45TCr	9.52TCr	12TCr	11TCr
Total Cash And Short Term Investments	3.85TCr	7.45TCr	9.52TCr	12TCr	11TCr
Accounts Receivable, Total	2.74TCr	5.18TCr	5.54TCr	6.17TCr	6.44TCr
Other Receivables	1.87TCr	2.91TCr	3.24TCr	3.78TCr	3.13TCr
Total Receivables	4.6TCr	8.09TCr	8.78TCr	9.95TCr	9.57TCr
Inventory	8.64TCr	14TCr	14TCr	14TCr	15TCr
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	468.9Cr	1.1TCr	1.03TCr	1.42TCr	1.16TCr
Total Current Assets	18TCr	30TCr	33TCr	37TCr	36TCr
Net Property Plant And Equipment	7.28TCr	11TCr	11TCr	11TCr	11TCr
Long-term Investments	11TCr	8.66TCr	9.56TCr	9.36TCr	9.57TCr
Goodwill	402.9Cr	12TCr	11TCr	11TCr	9.93TCr
Other Intangibles, Total	486.2Cr	2.43TCr	2.48TCr	2.75TCr	2.88TCr
Deferred Tax Assets Long-Term	534.9Cr	1.52TCr	1.51TCr	1.35TCr	1.38TCr
Other Long-Term Assets, Total	20L	20L	20L	10L	20L
Total Assets	37TCr	66TCr	69TCr	72TCr	71TCr
Liabilities
Accounts Payable, Total	5.55TCr	9.25TCr	10TCr	11TCr	11TCr
Accrued Expenses, Total	387.2Cr	570.9Cr	623.5Cr	560Cr	575.4Cr
Short-term Borrowings	-	88Cr	100Cr	97Cr	118.7Cr
Current Portion of Long-Term Debt	-	-	-	1.84TCr	-
Current Portion of Leases	198.1Cr	175.6Cr	111.9Cr	70Cr	41Cr
Current Income Taxes Payable	566Cr	1.15TCr	1.43TCr	1.74TCr	1.66TCr
Other Current Liabilities	1.79TCr	3.01TCr	2.82TCr	3.03TCr	3.05TCr
Total Current Liabilities	8.49TCr	14TCr	15TCr	18TCr	16TCr
Long-Term Debt	1.84TCr	1.84TCr	1.84TCr	-	-
Long-Term Leases	331.9Cr	188Cr	90Cr	59Cr	61Cr
Pension & Other Post Retirement Benefits	28Cr	593.2Cr	589.8Cr	40Cr	3.1Cr
Deferred Tax Liability Non Current	443Cr	954.5Cr	1.17TCr	890.2Cr	862Cr
Other Non Current Liabilities	1.11TCr	1.42TCr	1.53TCr	2.03TCr	1.94TCr
Total Liabilities	12TCr	19TCr	21TCr	21TCr	19TCr
Common Stock, Total	2.21TCr	2.21TCr	2.21TCr	2.21TCr	2.21TCr
Additional Paid In Capital	2.3TCr	21TCr	21TCr	21TCr	18TCr
Retained Earnings	21TCr	24TCr	26TCr	30TCr	34TCr
Treasury Stock	-2.07TCr	-643.9Cr	-1.81TCr	-2.14TCr	-2.49TCr
Comprehensive Income and Other	1.15TCr	650.3Cr	1.05TCr	682.7Cr	587.4Cr
Total Common Equity	25TCr	46TCr	48TCr	51TCr	52TCr
Minority Interest	-	2.4Cr	24Cr	45Cr	70Cr
Total Equity	25TCr	46TCr	48TCr	52TCr	52TCr
Total Liabilities And Equity	37TCr	66TCr	69TCr	72TCr	71TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	31Cr	42Cr	42Cr	42Cr	40Cr
ECS Total Common Shares Outstanding	31Cr	42Cr	42Cr	42Cr	40Cr
Book Value / Share	800.3	1.1T	1.15T	1.23T	1.29T
Tangible Book Value	24TCr	32TCr	34TCr	38TCr	39TCr
Tangible Book Value Per Share	771.42	756.97	823.81	914.61	973.22
Total Debt	2.37TCr	2.29TCr	2.14TCr	2.07TCr	220.5Cr
Net Debt	-1.48TCr	-5.16TCr	-7.38TCr	-9.71TCr	-11TCr
Debt Equivalent of Unfunded Proj. Benefit Obligation	28Cr	593.2Cr	589.8Cr	40Cr	3.1Cr
Debt Equivalent Oper. Leases	29TCr	41TCr	54TCr	57TCr	59TCr
Minority Interest, Total (Incl. Fin. Div)	-	2.4Cr	24Cr	45Cr	70Cr
Inventories - Raw Materials, Total	66Cr	68Cr	54Cr	78Cr	105Cr
Inventories - Finished Goods, Total	8.58TCr	14TCr	14TCr	14TCr	14TCr
Full Time Employees	6.69T	13.32T	13.66T	13.37T	12.75T
Accumulated Allowance for Doubtful Accounts (Supple)	6.2Cr	4.8Cr	3.6Cr	2.4Cr	7Cr

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	3.26TCr	4.96TCr	6.49TCr	8.12TCr	8.39TCr
Depreciation & Amortization - CF	773.8Cr	1.11TCr	1.43TCr	1.58TCr	1.61TCr
Amortization of Goodwill and Intangible Assets - (CF)	84Cr	380.9Cr	657.5Cr	658.4Cr	647.8Cr
Depreciation & Amortization, Total	857.8Cr	1.49TCr	2.08TCr	2.24TCr	2.26TCr
(Gain) Loss From Sale Of Asset	59Cr	491.9Cr	125.2Cr	241.7Cr	219Cr
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-274.1Cr	-70L
Other Operating Activities, Total	-1.08TCr	-1.31TCr	-2.03TCr	-2.86TCr	-2.13TCr
Change In Accounts Receivable	-393.7Cr	-81Cr	-340.1Cr	-626.3Cr	-271.2Cr
Change In Inventories	-453.8Cr	-47Cr	-460.1Cr	-280.1Cr	-581.7Cr
Change In Accounts Payable	-171Cr	-225.5Cr	921.6Cr	640.4Cr	103.2Cr
Change in Other Net Operating Assets	504.7Cr	-1.29TCr	-380.7Cr	-856.2Cr	161.4Cr
Cash from Operations	2.59TCr	3.98TCr	6.41TCr	6.35TCr	8.15TCr
Capital Expenditure	-363Cr	-931.7Cr	-1.36TCr	-1.32TCr	-883.4Cr
Sale of Property, Plant, and Equipment	-	-	185.3Cr	74Cr	162.4Cr
Cash Acquisitions	-28Cr	-149.6Cr	-9.3Cr	-422.1Cr	-499.8Cr
Divestitures	-	-	-	-	-
Sale (Purchase) of Intangible assets	-163.6Cr	-164.9Cr	-315.2Cr	-690.4Cr	-562.4Cr
Investment in Marketable and Equity Securities, Total	46Cr	8.6Cr	-	472.6Cr	19Cr
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-7Cr	-122.6Cr	-30L	-32Cr
Other Investing Activities, Total	-122.9Cr	-303.9Cr	-345.7Cr	-388.4Cr	-282.8Cr
Cash from Investing	-631.1Cr	-1.55TCr	-1.97TCr	-2.28TCr	-2.08TCr
Short Term Debt Issued, Total	-	-	26Cr	-	35Cr
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	26Cr	-	35Cr
Short Term Debt Repaid, Total	-	-57Cr	-	-9.1Cr	-
Long-Term Debt Repaid, Total	-	-42Cr	-	-	-1.84TCr
Total Debt Repaid	-	-99Cr	-	-9.1Cr	-1.84TCr
Issuance of Common Stock	-	-	16Cr	1Cr	2.8Cr
Repurchase of Common Stock	-	-900.9Cr	-1.19TCr	-368.9Cr	-3.1TCr
Common Dividends Paid	-719.3Cr	-827.2Cr	-1.06TCr	-1.33TCr	-1.68TCr
Common & Preferred Stock Dividends Paid	-719.3Cr	-827.2Cr	-1.06TCr	-1.33TCr	-1.68TCr
Other Financing Activities, Total	-221.6Cr	-206.3Cr	-172Cr	-125.1Cr	-85Cr
Cash from Financing	-940.9Cr	-2.03TCr	-2.37TCr	-1.83TCr	-6.67TCr
Foreign Exchange Rate Adjustments	-	-	-3Cr	2.3Cr	1.2Cr
Miscellaneous Cash Flow Adjustments	-20L	3.2TCr	7.7Cr	-10L	-
Net Change in Cash	1.02TCr	3.6TCr	2.07TCr	2.25TCr	-597Cr
Supplemental Items
Cash Interest Paid	4.4Cr	6Cr	5.3Cr	5.7Cr	6Cr
Cash Income Tax Paid (Refund)	1.13TCr	1.33TCr	2.02TCr	2.84TCr	2.12TCr
Levered Free Cash Flow	1.62TCr	-604.85Cr	4.96TCr	3.92TCr	6.16TCr
Unlevered Free Cash Flow	1.62TCr	-601.1Cr	4.96TCr	3.92TCr	6.16TCr
Change In Net Working Capital	681.2Cr	3.58TCr	-663.1Cr	1.03TCr	-220.1Cr
Net Debt Issued / Repaid	-	-99Cr	26Cr	-9.1Cr	-1.81TCr

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	5.47	5.05	5.79	6.69	7.14
Return on Total Capital	7.52	6.83	7.85	9.09	9.68
Return On Equity %	9.07	9.74	8.61	10.55	10.61
Return on Common Equity	9.07	9.73	8.56	10.5	10.56
Margin Analysis
Gross Profit Margin %	32.7	32.92	34.62	34.63	35.06
SG&A Margin	25.49	25.21	25.89	25.04	25.19
EBITDA Margin %	7.2	7.71	8.74	9.59	9.86
EBITA Margin %	5.81	6.19	7.24	8.04	8.34
EBIT Margin %	5.66	5.67	6.55	7.4	7.73
Income From Continuing Operations Margin %	3.87	4.74	4.29	5.15	5.18
Net Income Margin %	3.87	4.74	4.26	5.12	5.15
Net Avail. For Common Margin %	3.87	4.74	4.26	5.12	5.15
Normalized Net Income Margin	3.83	3.84	4.36	4.89	5.05
Levered Free Cash Flow Margin	2.9	-0.83	5.22	3.83	5.8
Unlevered Free Cash Flow Margin	2.91	-0.82	5.22	3.84	5.81
Asset Turnover
Asset Turnover	1.55	1.42	1.41	1.45	1.48
Fixed Assets Turnover	7.58	8.11	8.78	9.16	9.46
Receivables Turnover (Average Receivables)	21.92	18.44	17.74	17.46	16.83
Inventory Turnover (Average Inventory)	4.45	4.36	4.53	4.85	4.85
Short Term Liquidity
Current Ratio	2.07	2.14	2.15	2.07	2.24
Quick Ratio	1	1.09	1.19	1.21	1.28
Operating Cash Flow to Current Liabilities	0.3	0.28	0.42	0.35	0.5
Days Sales Outstanding (Average Receivables)	16.65	19.79	20.57	20.97	21.68
Days Outstanding Inventory (Average Inventory)	81.97	83.63	80.53	75.52	75.33
Average Days Payable Outstanding	54.35	49.91	57.34	56.84	56.24
Cash Conversion Cycle (Average Days)	44.27	53.51	43.77	39.64	40.77
Long Term Solvency
Total Debt/Equity	9.62	4.94	4.44	4.01	0.42
Total Debt / Total Capital	8.77	4.7	4.25	3.86	0.42
LT Debt/Equity	8.81	4.37	4	0.11	0.12
Long-Term Debt / Total Capital	8.04	4.16	3.83	0.11	0.12
Total Liabilities / Total Assets	33.19	29.3	29.85	28.92	26.84
EBIT / Interest Expense	716.41	690.13	1.18T	1.33T	1.28T
EBITDA / Interest Expense	911.36	937.82	1.57T	1.72T	1.64T
(EBITDA - Capex) / Interest Expense	828.86	782.53	1.31T	1.49T	1.5T
Total Debt / EBITDA	0.59	0.41	0.26	0.21	0.02
Net Debt / EBITDA	-0.37	-0.92	-0.89	-0.99	-1.05
Total Debt / (EBITDA - Capex)	0.65	0.49	0.31	0.24	0.02
Net Debt / (EBITDA - Capex)	-0.41	-1.1	-1.06	-1.14	-1.14
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-5.7	31.08	30.31	7.49	3.82
Gross Profit, 1 Yr. Growth %	-3.88	31.96	37.05	7.52	5.12
EBITDA, 1 Yr. Growth %	-12.74	40.32	47.71	17.93	6.8
EBITA, 1 Yr. Growth %	-15.85	39.72	52.27	19.44	7.69
EBIT, 1 Yr. Growth %	-16.06	31.36	50.4	21.48	8.5
Earnings From Cont. Operations, 1 Yr. Growth %	-17.6	60.48	17.78	29.07	4.55
Net Income, 1 Yr. Growth %	-17.6	60.37	17.22	29.11	4.45
Normalized Net Income, 1 Yr. Growth %	-14.74	31.54	48	20.64	7.08
Diluted EPS Before Extra, 1 Yr. Growth %	-17.62	34.77	1.74	30.51	6.81
Accounts Receivable, 1 Yr. Growth %	16.65	89.38	7.01	11.34	4.34
Inventory, 1 Yr. Growth %	5.54	59.6	-1.07	2.1	4.21
Net Property, Plant and Equip., 1 Yr. Growth %	-1.76	47.17	2.38	3.64	-2.45
Total Assets, 1 Yr. Growth %	4.86	78.01	4.78	5.32	-1.65
Tangible Book Value, 1 Yr. Growth %	8.04	35.1	7.34	10.74	2.95
Common Equity, 1 Yr. Growth %	7.48	88.39	3.91	6.69	1.18
Cash From Operations, 1 Yr. Growth %	4.49	53.86	60.91	-0.87	28.29
Capital Expenditures, 1 Yr. Growth %	-19.71	156.67	45.91	-2.83	-33.12
Levered Free Cash Flow, 1 Yr. Growth %	17.01	-137.4	-920.29	-20.98	57.14
Unlevered Free Cash Flow, 1 Yr. Growth %	17.12	-137.1	-925.95	-20.96	57.1
Dividend Per Share, 1 Yr. Growth %	0	0	0	58.57	18.92
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-1.67	11.18	30.69	18.35	5.64
Gross Profit, 2 Yr. CAGR %	0.73	12.63	34.48	21.39	6.32
EBITDA, 2 Yr. CAGR %	-4.82	10.65	43.97	31.98	12.23
EBITA, 2 Yr. CAGR %	-6.43	8.43	45.86	34.86	13.41
EBIT, 2 Yr. CAGR %	-6.46	5.01	40.56	35.17	14.81
Earnings From Cont. Operations, 2 Yr. CAGR %	-7.18	14.99	37.48	23.29	16.16
Net Income, 2 Yr. CAGR %	-7.18	14.95	37.11	23.02	16.12
Normalized Net Income, 2 Yr. CAGR %	-6.48	5.9	39.53	33.63	13.66
Diluted EPS Before Extra, 2 Yr. CAGR %	-6.32	5.37	17.1	15.23	18.07
Accounts Receivable, 2 Yr. CAGR %	7.97	48.63	42.35	9.15	7.78
Inventory, 2 Yr. CAGR %	6.08	29.78	25.65	0.5	3.15
Net Property, Plant and Equip., 2 Yr. CAGR %	-0.39	20.24	22.75	3.01	0.55
Total Assets, 2 Yr. CAGR %	7.65	36.63	36.57	5.05	1.78
Tangible Book Value, 2 Yr. CAGR %	9.16	20.81	20.42	9.03	6.77
Common Equity, 2 Yr. CAGR %	8.52	42.3	39.91	5.29	3.9
Cash From Operations, 2 Yr. CAGR %	8.7	26.79	57.35	26.3	12.77
Capital Expenditures, 2 Yr. CAGR %	-11.15	43.56	93.52	19.07	-19.39
Levered Free Cash Flow, 2 Yr. CAGR %	3.38	-33.85	75.15	154.59	11.43
Unlevered Free Cash Flow, 2 Yr. CAGR %	3.43	-34.08	75.06	155.5	11.43
Dividend Per Share, 2 Yr. CAGR %	3.77	0	0	25.93	37.32
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-0.12	8.22	17.22	22.45	13.3
Gross Profit, 3 Yr. CAGR %	2.48	10.22	20.24	24.82	15.71
EBITDA, 3 Yr. CAGR %	-0.95	8.33	21.84	34.71	22.99
EBITA, 3 Yr. CAGR %	-2.32	6.95	21.43	36.46	25.12
EBIT, 3 Yr. CAGR %	-2.07	4.75	18.37	33.89	25.62
Earnings From Cont. Operations, 3 Yr. CAGR %	-1.77	11.4	15.91	34.62	16.7
Net Income, 3 Yr. CAGR %	-1.77	11.38	15.7	34.39	16.49
Normalized Net Income, 3 Yr. CAGR %	-1.91	4.78	18.4	32.92	24.12
Diluted EPS Before Extra, 3 Yr. CAGR %	-0.76	5.75	4.15	21.41	12.35
Accounts Receivable, 3 Yr. CAGR %	9.39	30.21	33.21	31.16	7.52
Inventory, 3 Yr. CAGR %	7.1	21.55	18.56	17.25	1.72
Net Property, Plant and Equip., 3 Yr. CAGR %	0.44	13.45	13.96	16.02	1.15
Total Assets, 3 Yr. CAGR %	5.39	27.3	25.06	25.24	2.77
Tangible Book Value, 3 Yr. CAGR %	7.01	17.2	16.14	17.1	6.96
Common Equity, 3 Yr. CAGR %	6.35	30.43	28.14	27.82	3.9
Cash From Operations, 3 Yr. CAGR %	-2.52	22.05	37.27	34.89	26.96
Capital Expenditures, 3 Yr. CAGR %	2.17	26.54	44.33	53.81	-1.76
Levered Free Cash Flow, 3 Yr. CAGR %	-6.43	-26.34	53.11	34.33	116.76
Unlevered Free Cash Flow, 3 Yr. CAGR %	-6.39	-26.51	53.11	34.29	117.26
Dividend Per Share, 3 Yr. CAGR %	8.37	2.5	0	16.61	23.55
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	0.77	6.41	11.22	12.16	12.44
Gross Profit, 5 Yr. CAGR %	3.19	8.71	14.25	14.56	14.46
EBITDA, 5 Yr. CAGR %	2.76	9.12	15.03	17.23	17.9
EBITA, 5 Yr. CAGR %	2.42	8.84	14.67	17.34	18.15
EBIT, 5 Yr. CAGR %	2.83	7.81	13.16	15.99	16.93
Earnings From Cont. Operations, 5 Yr. CAGR %	3.83	11.46	12.37	16.01	16.01
Net Income, 5 Yr. CAGR %	3.85	11.45	12.25	15.9	15.87
Normalized Net Income, 5 Yr. CAGR %	2.74	7.78	12.94	15.49	16.48
Diluted EPS Before Extra, 5 Yr. CAGR %	4.77	8.42	6.03	9.45	9.51
Accounts Receivable, 5 Yr. CAGR %	8.67	23.79	21.54	21.34	22.39
Inventory, 5 Yr. CAGR %	5.76	15.29	14.17	12.65	12.14
Net Property, Plant and Equip., 5 Yr. CAGR %	0.22	8.49	8.83	9.15	8.4
Total Assets, 5 Yr. CAGR %	5.9	18.11	16.9	17.89	15.17
Tangible Book Value, 5 Yr. CAGR %	8.35	13.28	12.19	13.86	12.3
Common Equity, 5 Yr. CAGR %	7.5	20.33	18.69	19.72	17.83
Cash From Operations, 5 Yr. CAGR %	-3.6	10.91	18.05	23.73	26.89
Capital Expenditures, 5 Yr. CAGR %	-6.47	20.36	31.91	23.5	14.34
Levered Free Cash Flow, 5 Yr. CAGR %	-8.3	-14.9	20.24	20.97	34.84
Unlevered Free Cash Flow, 5 Yr. CAGR %	-8.28	-15.02	20.24	20.97	34.83
Dividend Per Share, 5 Yr. CAGR %	10.49	8.06	4.94	11.3	13.53